Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000528070 | SCV000645220 | uncertain significance | Severe combined immunodeficiency due to DCLRE1C deficiency | 2022-10-17 | criteria provided, single submitter | clinical testing | This sequence change replaces glutamic acid, which is acidic and polar, with valine, which is neutral and non-polar, at codon 462 of the DCLRE1C protein (p.Glu462Val). This variant is present in population databases (rs115250914, gnomAD 0.08%). This variant has not been reported in the literature in individuals affected with DCLRE1C-related conditions. ClinVar contains an entry for this variant (Variation ID: 468482). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Genome- |
RCV001563935 | SCV001786995 | uncertain significance | Histiocytic medullary reticulosis | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000528070 | SCV001786996 | uncertain significance | Severe combined immunodeficiency due to DCLRE1C deficiency | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002476172 | SCV002789330 | uncertain significance | Severe combined immunodeficiency due to DCLRE1C deficiency; Histiocytic medullary reticulosis | 2021-11-24 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004691886 | SCV005190649 | uncertain significance | not provided | criteria provided, single submitter | not provided |